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A tetracycline-regulated reporter system was used to investigate the regulation of cyclooxygenase 2 (Cox-2)
mRNA stability by the mitogen-activated protein kinase (MAPK) p38 signaling cascade. The stable b-globin
mRNA was rendered unstable by insertion of the 2,500-nucleotide Cox-2 3* untranslated region (3* UTR). The
chimeric transcript was stabilized by a constitutively active form of MAPK kinase 6, an activator of p38. This
stabilization was blocked by SB203580, an inhibitor of p38, and by two different dominant negative forms of
MAPK-activated protein kinase 2 (MAPKAPK-2), a kinase lying downstream of p38. Constitutively active
MAPKAPK-2 was also able to stabilize chimeric b-globin–Cox-2 transcripts. The MAPKAPK-2 substrate
hsp27 may be involved in stabilization, as b-globin–Cox-2 transcripts were partially stabilized by phospho-
mimetic mutant forms of hsp27. A short (123-nucleotide) fragment of the Cox-2 3* UTR was necessary and
sufficient for the regulation of mRNA stability by the p38 cascade and interacted with a HeLa protein
immunologically related to AU-rich element/poly(U) binding factor 1.
Eicosanoids play a critical role in several physiological and
pathophysiological processes, including blood clotting, wound
healing, kidney function, acute inflammation, and cardiovas-
cular disease (13, 19). The rate-limiting step in eicosanoid
synthesis is catalyzed by cyclooxygenase (Cox) enzymes, which
are encoded by two distinct genes. The Cox-1 gene is princi-
pally homeostatic in function and possesses a typical, GC-rich
housekeeping promoter (55). In contrast the Cox-2 gene
resembles an early response gene. It is strongly induced by
mitogenic and proinflammatory stimuli, superinduced by in-
hibitors of protein synthesis, and acutely regulated at both
transcriptional and posttranscriptional levels (17, 37–39, 46,
47). Posttranscriptional regulation is critical in determining the
strength and duration of Cox-2 gene induction by external
stimuli yet is poorly understood. Neither the sequences which
regulate Cox-2 mRNA metabolism nor the trans-acting factors
mediating this regulation have been identified.
Several proinflammatory treatments which induce Cox-2
gene expression also stimulate the mitogen-activated protein
kinase (MAPK) p38. This kinase is activated by phosphor-
ylation at threonine and tyrosine residues, catalyzed by the
dual-specificity kinase MAPK kinase 6 (MKK6) (11, 23, 42).
In turn, activated p38 phosphorylates numerous substrates
which include kinases such as MAPK-activated protein ki-
nase 2 (MAPKAPK-2) and -3 (18, 34, 49). Substrates of
MAPKAPK-2 and -3 include the small heat shock protein
hsp27, an abundant cytoplasmic protein of uncertain function
(15, 18, 53). In a variety of cells treated with different inducing
agents, specific inhibitors of p38 block the accumulation of
Cox-2 mRNA (21, 29, 33, 41, 43, 45). In HeLa cells stimulated
with interleukin 1 (IL-1) and in primary human monocytes
stimulated with bacterial lipopolysaccharide inhibition of p38
results in a rapid and specific destabilization of Cox-2 mRNA
but has little effect upon Cox-2 transcription (12, 44).
Regulation of mRNA stability is often mediated by se-
quences within the 39 untranslated region (39 UTR). Several
Cox-2 transcripts differing in 39 UTR length due to alternative
polyadenylation site usage have been described, the two major
transcripts being 4.6 and 2.8 kb long (38, 47). The most abun-
dant (4.6-kb) transcript has a 39 UTR of 2,515 nucleotides (nt),
containing 22 copies of the pentamer sequence AUUUA (see
Fig. 1). This sequence is found in the 39 UTRs of numerous
unstable cytokine- and protooncogene-encoding mRNAs and
is a prominent feature of AU-rich elements (AREs) which
regulate mRNA stability (6–8, 50). Two conserved regions
(CR) have been noted within the Cox-2 39 UTR (38). CR1 lies
immediately 39 to the translation termination codon and con-
tains six AUUUA motifs, of which three are overlapping. CR2
lies 1,700 nt 39 to the translation termination codon and con-
tains three dispersed AUUUA motifs (Fig. 1).
Several proteins have been shown to interact specifically
with AU-rich RNA stability determinants, and have been im-
plicated in positive or negative regulation of mRNA stability.
For example ARE/poly(U) binding factor 1 (AUF1), a mem-
ber of the hnRNP D family of RNA binding proteins, is
present in a cytosolic fraction which accelerates c-myc mRNA
decay in vitro (3, 60). Increased AUF1 expression is associated
with decreased mRNA stability in vivo (5, 40, 53), and AUF1
overexpression can antagonize mRNA stabilization in vivo
(31). Furthermore the immunodepletion of AUF1 from cyto-
plasmic extracts increases the stability of an ARE-containing
transcript in an in vitro degradation assay (4).
The tetracycline-responsive reporter system (20, 59) permits
regulatory sequences and pathways to be mapped by perform-
ing RNA stability experiments in the absence of toxic tran-
scriptional inhibitors. Reporter mRNAs are transcribed from a
tetracycline-responsive promoter in a cell line expressing a
chimeric, tetracycline-responsive transcription factor, tTA
(20). In the presence of tetracycline, binding of tTA to the
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promoter is blocked and transcription is inhibited. Using this
system, referred to herein as the TET-off system, we demon-
strate that the effects of p38 are mediated by its downstream
kinase MAPKAPK-2 and may involve the phosphorylation of
the MAPKAPK-2 substrate hsp27. A conserved, 123-nucleo-
tide ARE lying immediately 39 to the translation termination
codon (CR1) is necessary and sufficient for stabilization by the
p38 pathway and interacts with a HeLa cell protein which is
immunologically related to AUF1.
MATERIALS AND METHODS
Plasmids. The MKK6E expression vector was a gift of J. Han. MAPKAPK-2
expression vectors were donated by C. Marshall. Human Cox-2 39 UTR frag-
ments were amplified by reverse transcription-PCR from IL-1-stimulated human
gingival fibroblast RNA, using Moloney murine leukemia virus reverse transcrip-
tase and Vent polymerase (NEB). Human tumor necrosis factor alpha (TNF-a)
and c-myc 39 UTR fragments were amplified from genomic DNA using TaqPlus
polymerase (Stratagene). A mouse TNF-a 39 UTR fragment was amplified from
a mouse TNF-a genomic clone (gift of A. Shakhov), using Vent polymerase.
PCR products were cloned into pCR-Blunt (Invitrogen) and then excised with
BglII or BamHI and cloned into the BglII site of pTetBBB (gift of Ann-Bin
Shyu).
Riboprobe vectors were constructed as follows. A 352-bp HincII-XbaI lucif-
erase fragment was cloned from pGL3c (Promega) into pBluescript KS that had
been digested with EcoRV and XbaI. A 256-bp BstYI-ClaI fragment was cloned
from a human Cox-2 cDNA construct (gift of D. Fitzgerald) into pBluescript KS
that had been digested with BamHI and ClaI. A 269-bp SspI-BglII fragment was
cloned from pTetBBB into pBluescript KS that had been digested with BamHI
and EcoRV. To construct hsp27 expression vectors, the hsp27 open reading
frame was excised from pGEX2T-hsp27 (gift of S. Lumb), using BamHI, and
cloned in frame at the BamHI site of pFlagCMV2 (Sigma-Aldrich). Mutagenesis
was performed with the QuikChange kit (Stratagene). Sequences of oligonucle-
otides are available on request from the corresponding author. Novel DNA
constructs were commercially sequenced by ABC (London, United Kingdom).
Cell culture and transfection. HeLa-TO cells (Clontech) were maintained in
Dulbecco’s modified Eagle medium–10% fetal calf serum supplemented with
G-418 (100 ng/ml; Life Technologies). Cells were seeded in six-well plates at a
density of 1.5 3 105 cells/well. The following day cells were transfected using
Superfect (Qiagen). The amount of total transfected DNA was kept constant
within all experiments by addition of appropriate empty expression vectors
and/or Bluescript plasmid (Stratagene). After 24 h, tetracycline (Sigma) was
added at a final concentration of 100 ng/ml, and cells were harvested in guanidine
thiocyanate lysis buffer (Ambion) at different intervals, as indicated in each
figure. Lysates were passed through shredder columns (Qiagen) and stored
frozen at 220°C. In some experiments 1 mM SB203580 (Calbiochem) or vehicle
control (dimethyl sulfoxide [0.03%]) was added to cells 30 min prior to the
addition of tetracycline.
Ribonuclease protection assay. Riboprobe template constructs were linearized
by appropriate restriction digestion and purified by phenol-chloroform extraction
and ethanol precipitation. Riboprobes were synthesized using T7 polymerase
(Boehringer Mannheim) in the presence of 50 mCi of [a-32P]UTP (800 Ci/mmol;
Amersham). The final concentration of unlabeled UTP in in vitro transcription
reactions was 12 mM, except in the case of GAPDH (glyceraldehyde-3-phosphate
dehydrogenase), where it was 36 mM. Ribonuclease protection assays were car-
ried out using the Direct Protect kit (Ambion). Under the conditions of hybrid-
ization DNA-RNA heteroduplexes are not detected. Protected RNA fragments
were resolved by electrophoresis on denaturing 6% polyacrylamide gels and were
visualized and quantified by phosphorimaging (Fuji FLA 2000) and autoradiog-
raphy. Autoradiographs are shown in all figures. Each experiment was performed
at least twice, and serial dilutions of lysates were used to check that quantitations
were within the linear range of the assay.
Western blotting. HeLa-TO cells in six-well dishes were transfected with 780
ng of wild-type or mutant hsp27 expression vector and 220 ng of pBluescript as
described above. After 24 h proteins were harvested in radioimmunoprecipita-
tion assay buffer, separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis and electrophoretically transferred to nitrocellulose (Sartorius). The
membrane was probed with a mouse monoclonal antibody to the flag epitope
(anti-Flag M2 [Sigma-Aldrich]) and then with a peroxidase-coupled second an-
tibody (Dako). Proteins were detected using the enhanced chemiluminescence
system (Amersham).
Preparation of HeLa extracts. HeLa-TO cells were grown to confluence in
175-cm2 flasks. The cells were cooled on ice for 5 min, rinsed once with ice-cold
phosphate-buffered saline, and lysed by addition of a buffer containing 10 mM
HEPES (pH 7.6), 3 mM MgCl2, 40 mM KCl, 2 mM dithiothreitol, 5% glycerol,
0.5% NP-40, and protease inhibitors (0.5 mM phenylmethylsulfonyl fluoride, 10
mM E64, and 4 mg of aprotinin and 4 mg of pepstatin per ml). After 15 min on
ice, nuclei were removed by centrifugation at 600 3 g for 10 min. The superna-
tant was aliquoted and snap frozen at 270°C.
RNA band shift assay. RNA probes were synthesized essentially as described
for the ribonuclease protection assay. RNA band shift assays were performed
according to the method of Hel et al. (25). The protein extracts were incubated
with the indicated RNA probes in a buffer containing 20 mM HEPES (pH 7.6),
3 mM MgCl2, 40 mM KCl, 2 mM dithiothreitol, and 5% glycerol. Typically, 10
mg of protein was incubated for 20 min with 400,000 to 500,000 cpm of a-32P-
labeled RNA probe, corresponding to approximately 10 fmol of RNA. RNase T1
and heparin sulphate were added to final concentrations of 50 U/ml and 5 mg/ml,
respectively, and the reaction was allowed to continue for a further 20 min on ice.
Three microliters of loading buffer (90% glycerol, 0.025% bromophenol blue)
was added to the samples which were then resolved by electrophoresis at 4°C on
a 0.53 Tris-borate-EDTA nondenaturing 4% polyacrylamide gel. Gels were
subjected to autoradiography and phosphorimaging. In some experiments bind-
ing reactions also contained homopolyribonucleotides (Pharmacia) as indicated,
or 1 ml of polyclonal antiserum. HuR (gift of J. Steitz), Jun N-terminal protein
kinase (JNK3), and AUF1 antisera were all raised in rabbits.
RESULTS
The Cox-2 3* UTR mediates regulation of mRNA stability by
the p38 pathway. The tetracycline-responsive reporter con-
struct pTetBBB (59), contains a rabbit b-globin genomic frag-
ment downstream of tetracycline operator sequences and a
minimal promoter (Fig. 1). Transcriptional activity of this con-
struct was rapidly switched off by addition of 100 ng/ml tetra-
cycline to the culture medium (unpublished data).
A cDNA fragment encoding the Cox-2 39 UTR was inserted
at the BglII site of pTetBBB (Fig. 1). The resulting construct
(pTetBBB-Cox2.5) was transiently transfected into HeLa-TO
cells with a luciferase expression vector and with or without a
vector expressing constitutively active MKK6. After 24 h cells
were treated with SB203580 or vehicle, and then tetracycline
was added and cells were harvested at intervals as indicated in
Fig. 2. A ribonuclease protection assay was used to quantify the
b-globin–Cox2.5 reporter transcript, Cox-2, luciferase, and
GAPDH mRNAs (the last two as controls for transfection
efficiency and gel loading). In all such experiments endogenous
Cox-2 expression was up-regulated by MKK6, and this was
FIG. 1. Structure of Cox-2 mRNAs and construction of posttranscriptional
reporters. (A) Structure of the major (4.6-kb) Cox-2 transcript. AUUUA motifs
are shown as vertical bars. CR1 contains six of these motifs, and CR2 contains
three. Polyadenylation sites (PA1 to PA3) are represented as vertical arrows,
with the two major sites indicated by larger arrows. Canonical (AATAAA)
polyadenylation sites are indicated by arrows with closed triangles heads; non-
canonical (ATTAAA) sites are indicated by arrows with Vs for heads. The
polyadenylation sites are discussed in the text. ORF, open reading frame. (B)
Schematic of 39 UTR-encoding fragments generated by PCR and cloned into the
BglII site of pTetBBB. (C) Structure of the reporter construct pTetBBB. Rabbit
b-globin exons and introns are shown as closed and open bars. Translation
initiation (ATG), translation termination (TGA), and polyadenylation (AATA
AA) signals are indicated. The antisense b-globin riboprobe is represented as a
dashed arrow. TetOp, tetracycline operator sequences, TATA, minimal cyto-
megalovirus promoter.
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reversed by SB203580, confirming that the Cox-2 gene is a
target for the p38 pathway in this particular HeLa cell line.
Up-regulation of luciferase expression by MKK6 was not re-
producible. The antisense b-globin probe spans an intron-exon
boundary (Fig. 1), and detects an unspliced pre-mRNA spe-
cies, which is indicated in Fig. 2A. Following the addition of
tetracycline, this pre-mRNA rapidly disappeared, as transcrip-
tion was inhibited and the pre-mRNA was processed.
Little or no decay of the b-globin transcript was detected
over a 6-h tetracycline chase (see Fig. 4 for this and additional
controls). In contrast the chimeric b-globin–Cox2.5 transcript
decayed with a half-life of approximately 1 h. In the presence
of constitutively active MKK6, the half-life of this transcript
increased more than twofold. MKK6 coexpression increased
the quantity of transcript detected at the start of the tetracy-
cline chase, presumably because the increased transcript sta-
bility resulted in a greater mRNA accumulation during the
24 h prior to the addition of tetracycline. The addition of 1 mM
SB203580 shortly before the addition of tetracycline reversed
the MKK6-dependent stabilization of the chimeric transcript.
In spite of very different starting levels, the transcripts decayed
with identical half-lives in the absence of MKK6 or in the
presence of both MKK6 and SB203580. Therefore, differences
in rates of decay do not simply reflect limited capacity within
the degradative machinery but are related to the activity of the
p38 pathway. In HeLa cells phorbol myristate acetate is a
potent activator of MAPKs p42 and p44 but not p38 and
strongly induces expression of the Cox-2 gene. Treatment of
HeLa-TO cells with phorbol myristate acetate had no impact
upon the stability of the b-globin–Cox2.5 chimeric mRNA
(unpublished data). The Cox-2 39 UTR therefore confers in-
stability and p38-dependent stabilization upon a heterologous
mRNA.
CR1 of the Cox-2 3* UTR is necessary and sufficient for the
regulation of mRNA stability by the p38 pathway. To deter-
mine what proportion of the 2,515-nt Cox-2 39 UTR is required
for p38-mediated regulation of stability, we initially cloned 1.4-
and 0.6-kb 39 UTR fragments into pTetBBB (Fig. 1). These
fragments correspond to the 39 UTRs present within two mi-
nor Cox-2 transcripts, which terminate at noncanonical ATT
AAA polyadenylation signals (PA1 and PA2 in Fig. 1) (38, 47).
The b-globin–Cox1.4 and b-globin–Cox0.6 transcripts behaved
similarly to b-globin–Cox2.5 (Fig. 3). Therefore, only the first
600 nt of the Cox-2 39 UTR is required for the regulation of
mRNA stability by the p38 pathway and CR2 is dispensible.
This is in agreement with our previous observation that endog-
enous 4.6- and 2.8-kb Cox-2 transcripts are identically desta-
bilized by SB203580 in actinomycin D chase experiments (12,
44).
The 0.6-kb 39 UTR fragment was further subdivided into a
0.1-kb fragment which contained six AUUUA repeats (equiv-
alent to CR1) and a 0.5 kb fragment which contained only one
AUUUA sequence (Fig. 1). The b-globin–Cox0.5 transcript
was stable under all conditions (Fig. 3). In contrast the b-glo-
bin–Cox0.1 transcript was unstable and was very strongly sta-
bilized by MKK6. This effect was significantly reversed in the
presence of 1 mM SB203580 (Fig. 3). We conclude that CR1
contains all of the sequence elements required to mediate the
regulation of mRNA stability by the p38 pathway. Under all
p38-activating conditions tested, the b-globin–Cox0.1 tran-
script was stabilized more strongly than b-globin–Cox0.6 or
any of the other chimeric mRNAs. In addition to CR1, the
Cox-2 39 UTR may therefore contain additional determinants
of mRNA instability which do not respond to activation of the
p38 pathway. The b-globin–Cox0.5 transcript is highly stable,
suggesting that additional instability determinants function
only in the presence of CR1.
Sequence specificity of p38-regulated mRNA stability. CR1
contains overlapping AUUUA motifs and thus resembles a
class II ARE (7). In contrast, class I AREs are characterized by
dispersed AUUUA motifs in association with U-rich stretches.
To investigate the sequence specificity of p38-mediated regu-
lation of mRNA stability, the MKK6 responsiveness of several
control transcripts was tested. These transcripts contained no
insert, a class II ARE derived from the TNF-a 39 UTR, a class
I ARE derived from the c-myc 39 UTR, or CR1 in reverse
orientation [b-globin and b-globin–TNF, –myc and –Cox0.1
[as], respectively]. The b-globin–TNF and b-globin–myc tran-
scripts were unstable but unresponsive to MKK6 or SB203580
(Fig. 4); therefore, the regulation of mRNA stability by p38 is
FIG. 2. The Cox-2 39 UTR mediates regulation of mRNA stability by the p38
pathway. HeLa-TO cells were transfected with 200 ng of pGL3c, 20 ng of
pTetBBB-Cox2.5, and 100 ng of MKK6 expression vector or empty vector con-
trol (pcDNA3). After 24 h vehicle control (dimethyl sulfoxide) or SB203580 (1
mM) was added. After a further 30 min, tetracycline was added to a final
concentration of 100 ng/ml. Cells were harvested at the time intervals shown, and
ribonuclease protection assays were performed to quantify luciferase, Cox-2,
b-globin–Cox2.5, and GAPDH mRNAs. (A) A representative experiment. Ri-
bonuclease protected luciferase (Lux), Cox-2, GAPDH, b-globin–Cox2.5 and
pre-b-globin (Pre-G) fragments are indicated. (B) Graphical representation of
means 6 standard deviations (error bars) of seven independent experiments.
b-globin/GAPDH ratios were plotted as percentage of the maximum value at the
time of tetracycline addition.
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not a general property of AREs. Neither synthesis nor degra-
dation of the highly stable b-globin transcript from the tetra-
cycline-regulated promoter was influenced by MKK6. The
CR1 fragment did not confer instability or MKK6 responsive-
ness when placed in reverse orientation; therefore, it does not
possess enhancer-like properties, and transcriptional effects of
MKK6 coexpression can be discounted. Further, the regulation
of mRNA stability by p38 is not simply a consequence of the
high (78%) AU content of CR1, as this AU richness is pre-
served in b-globin–Cox0.1(as). Finally, all chimeric b-globin
transcripts were assessed by Northern blotting and shown to be
of the anticipated sizes (data not shown).
Regulation of mRNA stability is mediated by MAPKAPK-2.
To further dissect the role of the p38 pathway in the regulation
of Cox-2 mRNA stability, we used a series of mutants of
MAPKAPK-2, a kinase which is phosphorylated and activated
by p38 (18, 49). Wild-type MAPKAPK-2 had little or no im-
pact upon the stability of b-globin–Cox0.1 transcripts; how-
ever, a constitutively active form (AspX3) (2) strongly stabi-
lized the reporter transcript (Fig. 5A and 5C). Stabilization was
also observed with b-globin–Cox2.5 and was not affected by 1
mM SB203580, consistent with the site of action of the drug in
the p38 signal transduction cascade (unpublished data).
The stabilization of b-globin–Cox0.1 by MKK6 was blocked
by two distinct dominant negative forms of MAPKAPK-2 (1),
a nonphosphorylatable mutant (A222/334) and a kinase dead
mutant (A207) (Fig. 5B and 5D). We observed a slight but
reproducible additive stabilization of the reporter transcript by
coexpression of MKK6 and wild-type MAPKAPK-2. Virtually
identical results were obtained with b-globin–Cox2.5 (unpub-
lished data). The results described here suggest that the regu-
lation of mRNA stability by the p38 pathway is mediated
largely or entirely by the p38 substrate MAPKAPK-2.
Chimeric b-globin–Cox transcripts are partially stabilized
by hsp27 mutants. The only known substrates of the kinase
MAPKAPK-2 are the transcription factors ATF1, CREB, and
SRF (24, 26, 54) and the small heat shock protein hsp27 (15,
18, 53). hsp27 is an abundant cytoplasmic protein thought to
play a role in cell survival following stress (14, 28, 35).
MAPKAPK-2 phosphorylates three serine residues (15, 78,
and 82) in human hsp27 and two serine residues (15 and 90) in
the rodent homologue hsp25. Phosphorylation is thought to
regulate the functional properties of the small heat shock pro-
teins in part by controlling their association into dimers or
homopolymers (27, 48). Self-association is primarily regulated
by S90 phosphorylation in hamster hsp25. Phosphorylation of
FIG. 3. CR1 is necessary and sufficient for the regulation of mRNA stability by the p38 pathway. Transfections and ribonuclease protection assays were performed
as described in the legend to Fig. 2, using the reporter constructs pTetBBB-Cox1.4, -Cox0.6, -Cox0.5, and -Cox0.1. SB, 1 mM SB203580. (A) Representative experiments.
Only the b-globin reporter and GAPDH loading control bands are shown. (B) Graphical representation of the experiments shown in panel A. Each transfection was
performed at least twice, with qualitatively identical results.
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S15 has little or no effect upon self-association but may regu-
late the interaction of hsp25 and/or hsp27 with other cellular
proteins such as actin (27).
To investigate the potential role of hsp27 in the regulation of
Cox-2 mRNA stability, we generated mutants in which serine
15, serines 78 and 82, or all three phospho-acceptor serines
were mutated to alanine or glutamic acid. The triple glutamate
substitution mutant hsp27EEE stabilized b-globin-Cox0.1
mRNA, while the single and double glutamate substitution
mutants had less effect (Fig. 6A). Virtually identical results
were obtained with b-globin–Cox2.5 (unpublished data). Equal
expression of all mutants was confirmed by Western blotting
(Fig. 6C).
The phosphorylation of hsp27 may contribute to the stabi-
lization of mRNA by the MAPK p38 pathway, with a poten-
tial role for each of the sites in hsp27 phosphorylated by
MAPKAPK-2. In this assay system the stabilizing effect of
hsp27EEE was weak compared to that of MKK6 (Fig. 6) or
MAPKAPK-2 itself (Fig. 5), and the alanine substitution mu-
tants had no dominant negative effect on stabilization by
MKK6 (unpublished data). However, the effects of phosphor-
ylation site substitutions in a noncatalytic protein such as hsp27
are difficult to predict, especially within a cell which abundantly
expresses the wild-type protein. In order to rule out or to
prove more conclusively that hsp27 is involved in the regula-
tion of mRNA stability, it may be necessary to use hsp27
knockout cells. It is possible that an unidentified substrate of
MAPKAPK-2 plays a more significant role in this process.
CR1 interacts with AUF1 or an immunologically related
protein. In electrophoretic mobility shift assays using a Cox0.1
probe and a HeLa-TO cytoplasmic extract three protein-RNA
complexes were observed, with the lowest mobility complex
(C3 in Fig. 7) being rather diffuse. No complexes were detected
with the Cox0.5 or Cox0.1 antisense probes. All protein inter-
actions with the Cox0.1 probe could be blocked by competition
with an excess of unlabeled poly(U) but not with poly(A) (Fig.
7B), poly(C), or poly(G) (unpublished data). Complexes C3
and C4 were common to Cox0.1 and c-myc probes, while com-
plex C5 was detected only with the Cox0.1 probe and com-
plexes C1 and C2 were common to c-myc and TNF-a probes
(Fig. 8B).
The ARE-binding proteins AUF1 and HuR are both present
in HeLa cells and bind to the c-myc 39 UTR and to poly(U)
RNA (3, 32, 36, 60). Because of the similarities between
Cox0.1 and c-myc RNA-protein complexes, we hypothesized
that AUF1, HuR, or both proteins might interact with the CR1
FIG. 4. Sequence specificity of p38-regulated mRNA stability. Transfections and ribonuclease protection assays were performed as described in the legend to Fig.
2, using the reporter constructs pTetBBB, pTetBBB-Cox0.1(as), pTetBBB-TNF, and pTetBBB-myc. SB, 1 mM SB203580. (A) Representative experiments. Only the
b-globin reporter and GAPDH loading control bands are shown. (B) Graphical representation of the experiments shown in panel A. Each transfection was performed
at least twice, with qualitatively identical results.
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sequence. Therefore, electrophoretic mobility shift assays were
carried out using HeLa-TO cytoplasmic extract and Cox0.1
probe in the presence of antibodies raised against HuR, AUF1,
or an irrelevant protein (JNK3) (Fig. 8A). A supershifted com-
plex was detected in the presence of the AUF1 antibody, sug-
gesting that a protein which interacts with the CR1 sequence is
identical (or closely related) to AUF1. No supershifted com-
plexes were detected with a nonimmune serum or with HuR or
JNK3 antiserum. An anti-AUF1 supershifted complex was also
detected using the c-myc but not the TNF-a probe (Fig. 8B).
The formation of supershifted bands was not accompanied by
substantial reduction of RNA-protein complexes C3 to C5.
Immunodepletion of AUF1 from the HeLa-TO cytoplasmic
extract did not significantly inhibit the formation of complexes
C3 to C5 (unpublished data). Therefore, an AUF1-related
protein is present in HeLa-TO cells and is able to bind to the
CR1 probe but represents only a small proportion of the CR1-
binding activity detected in electrophoretic mobility shift assays.
DISCUSSION
We previously reported that Cox-2 mRNA stability is regu-
lated by p38 in human monocytes and in HeLa cells (12, 44).
Those studies employed pharmacological inhibitors of tran-
scription and of p38, each of which is a potential source of
artifacts. The transcriptional inhibitor actinomycin D is cyto-
toxic, induces nucleocytoplasmic shuttling of several RNA
binding proteins (16, 22), and may artificially stabilize some
mRNAs (9, 51, 58). At high concentrations SB203580 is able to
inhibit some JNK isoforms (10, 56), although at the 1 mM
concentration we have used there is little or no effect upon
HeLa cell JNK activity (44). At the concentration used, tetra-
cycline has no discernible effects upon HeLa-TO cells other
than the regulation of the tetracycline-responsive promoter.
The present study, using a tetracycline chase procedure, pro-
vides proof of p38-dependent Cox-2 mRNA stabilization, op-
erating through the p38 substrate MAPKAPK-2, and possibly
FIG. 5. Regulation of stability of chimeric b-globin–Cox-2 transcripts is mediated by MAPKAPK-2. (A) HeLa-TO cells were transfected with 200 ng of pGL3c, 20
ng of pTetBBB-Cox0.1, and 780 ng of empty vector or MAPKAPK-2 expression vector as indicated. Ribonuclease protection assays were performed as described in
the legend to Fig. 2. wt, wild type; Aspx3, constitutively active mutant. (B) HeLa-TO cells were transfected with 200 ng of pGL3c, 20 ng of pTetBBB-Cox0.1, 100 ng
of MKK6 expression vector or the corresponding empty vector, and 500 ng of MAPKAPK-2 expression vector as indicated, or the corresponding empty vector.
Ribonuclease protection assays were performed as described in the legend to Fig. 2. (C) Graphical representation of the experiment shown in panel A. (D) Graphical
representation of the experiment shown in panel B. Each experiment was performed at least twice, with qualitatively identical results.
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mediated in part by the phosphorylation of the small heat
shock protein hsp27.
The p38-dependent stabilization of mRNA is sequence-spe-
cific, since 39 UTR sequences derived from c-myc or TNFa
destabilise the b-globin reporter transcript, but do not confer
responsiveness to the p38 pathway. Using a similar system, it
has recently been demonstrated that the p38 pathway regulates
the stability of reporter transcripts containing IL-6, IL-8, c-fos,
and granulocyte-macrophage colony-stimulating factor (GM-
CSF) AREs (57). Thus, p38 is able to regulate the stability of
a subset of mRNAs containing class I AREs and a subset of
mRNAs containing class II AREs. For comparison, several of
the relevant ARE sequences are illustrated in Fig. 9. The
TNF-a ARE is strikingly similar to CR1, and we find endog-
enous TNF-a mRNA stability to be regulated by p38 in
RAW264.7 mouse macrophage cells (unpublished data).
The basis of selectivity of p38 action is not clear, but such
selectivity most likely arises from specific protein-RNA inter-
actions. We have shown that CR1 interacts with AUF1, a
member of the hnRNP D family which may be involved in the
degradation of labile mRNAs (4, 5, 30, 40, 52, 60). AUF1 is a
relatively small proportion of the CR1-binding activity de-
tected in electrophoretic mobility shift assays. However, the
cell contains multiple ARE-binding factors which may not
function in the control of degradation; therefore, this finding
does not rule out an involvement of AUF1 in the regulation of
Cox-2 mRNA stability by p38 (4, 5, 52). AUF1 is a relatively
minor component of the binding activity detected using a GM-
CSF 39 UTR probe. However, the depletion of AUF1 from
cytoplasmic extracts greatly increases the stability of GM-CSF
RNA in an in vitro degradation system (4, 5). As AUF1 inter-
acts with the c-myc 39 UTR, which is not p38 responsive, the
binding of AUF1 alone cannot account for p38 sensitivity. One
possibility is that signal-responsive stabilization involves a p38-
dependent displacement of AUF1 from its binding site. Fur-
ther experiments are required to determine the involvement
(or noninvolvement) of both AUF1 and HuR. We also hope to
FIG. 6. Stabilization of a b-globin–Cox chimeric transcript by a mutant of
hsp27. (A) HeLa-TO cells were transfected with 200 ng of pGL3c and 20 ng of
pTetBBB-Cox0.1, plus 100 ng of MKK6 expression vector or 780 ng of Flag-
hsp27 expression vector as indicated. Ribonuclease protection assays were per-
formed as described in the legend to Fig. 2. (B) Graphical representation of the
experiment shown in panel A. This experiment was performed three times, with
qualitatively identical results. (C) HeLa-TO cells were transfected with 780 ng of
pFlagCMV2 (first lane) or Flag-hsp27 expression vector as indicated. After 24 h
cells were harvested and Western blotting was performed using an antibody
against the Flag epitope.
FIG. 7. The p38-responsive region of the Cox-2 39 UTR forms several com-
plexes with HeLa-TO cytoplasmic proteins. Complexes C3 to C5 are discussed in
the text. FP, free probe. (A) Electrophoretic mobility shift assays were per-
formed using Cox0.1, Cox0.1 antisense, and Cox0.5 RNA probes and 10 mg of
HeLa-TO cytoplasmic extract. (B) Electrophoretic mobility shift assays were
performed using a Cox0.1 RNA probe and 10 mg of HeLa-TO cytoplasmic
extract in the presence of a 0- to 1,000-fold excess (by mass) of homopolyribo-
nucleotides poly(A) or poly(U), as indicated.
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define determinants of p38 responsiveness by extending the
comparison of p38-sensitive and -insensitive ARE-containing
transcripts using the system described here. It will also be
interesting to extend the comparison of RNA-protein com-
plexes involving p38-sensitive and p38-insensitive AREs and to
determine whether the formation of complex C5 is specific to
p38-sensitive AREs.
The most-abundant (4.6-kb) Cox-2 transcript contains a
2,515-nt 39 UTR, while the second-most-abundant (2.8-kb)
transcript contains a 603-nt 39 UTR (38, 47). Only 123 nt,
immediately 39 to the translation termination codon, are re-
quired for the regulation of mRNA stability by p38. Evolution-
ary conservation of p38-mediated stability regulation is sug-
gested by the high degree of conservation of this region
(between mouse and human transcripts: 77% for CR1, 100%
for the AUUUA motifs within CR1, and 64% for the entire 39
UTR). The 4.6- and 2.8-kb transcripts are similarly destabilized
by inhibition of p38 (12, 44) but are differentially destabilized
by the anti-inflammatory glucocorticoid dexamethasone (47),
suggesting an involvement of distal sequences (possibly CR2).
Regulation of stability by dexamethasone requires glucocorti-
coid receptor-mediated gene expression and could not be re-
constituted using posttranscriptional reporter constructs (37,
46, 47). The p38 and glucocorticoid pathways therefore seem
to employ distinct mechanisms and distinct cis-acting se-
quences to regulate Cox-2 mRNA stability. Thus, both tran-
scriptional and posttranscriptional regulatory elements of the
Cox-2 gene have evolved a capacity to respond to diverse
extracellular signals.
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